Effects of intestinal trefoil factor on colonic mucosa in experimental colitis of rats

Abstract

In order to investigate the protective effects of intestinal trefoil factor (ITF) on colonic mucosa in experimental colitis of rats, ITF was detected by RT-PCR and immunohistochemistry at different time points. Three days after colitis induction, rats were treated with either 0.9% saline solution or rhITF. Pathological changes and the expression of iNOS mRNA, NO, MDA and SOD were measured respectively. It was found that ITF was mainly located in goblet cells, significantly higher in model group than in normal group (P<0.05). rhITF could increase the iNOS mRNA expression and NO contents, and there was statistically significant difference between rhITF group and model group (P<0.05). rhITF also caused an increases of MDA and a decrease of SOD, but there was no significant difference between two groups. These results indicated that ITF has apparent therapeutic effects in ulcerative colitis, which may be associated with iNOS and NO.

Keywords

intestinal trefoil factor / experimental colitis / mucosa protection / nitric oxide

References

[1] WongW M, PoulsomR, WrightN A. Trefoil peptides. Gut, 1999, 44(6): 890-890

[2] TranC P, CookG A, YeomansN D, et al.. Trefoils peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut, 1999, 44(5): 636-636

[3] MillarA D, RamptonD S, ChanderC L, et al.. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut, 1996, 39(3): 407-407

[4] ThimL, MadsenF, PoulsenS S. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest, 2002, 32(7): 519-519

[5] RenesI B, VerburgM, Van NispenD J, et al.. Distinct epithelial responses in experimental colitis: implications for ion uptake and mucosal protection. Am J Physiol Gastrointest Liver Physiol, 2002, 283(1): G169-G169

[6] DikopoulosN, NusslerA K, LiptayS, et al.. Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis. Eur J Clin Invest, 2001, 31(3): 234-234

[7] SalasA, GironellaM, SalasA, et al.. Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice. Lab Invest, 2002, 82(5): 597-597

[8] TakahashiA, TomomasaT, KanekoH, et al.. Intestinal motility in an in vivo rat model of intestinal ischemiareperfusion with special reference to the effects of nitric oxide on the motility changes. J Pediatr Gastroenterol Nutr, 2001, 33: 283-283

[9] CrossR K, WilsonK T. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis, 2003, 9(3): 179-179

[10] GiraudA S, PereiraP M, ThimL, et al.. TFF-2 inhibits iNOS/NO in monocytes, and nitrated protein in healing colon after colitis. Peptides, 2004, 25(5): 803-803